Anixa Biosciences Inc
Ownership
Ownership Structure
Who owns Anixa Biosciences Inc (ANIX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 94.4% of the shares are freely tradable; institutional investors hold 15.1%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Capital Management, LLC | 3.83 | 1,329,852 | +1.1 | 06/30/2026 |
| UBS Group AG | 1.68 | 585,430 | +6.1 | 06/30/2026 |
| Laird Norton Tyee Trust Co | 1.66 | 578,727 | +2.2 | 06/30/2026 |
| Davidson D A & Co | 1.55 | 539,272 | +0.0 | 06/30/2026 |
| Geode Capital Management, LLC | 1.03 | 359,194 | -1.5 | 06/30/2026 |
| Marshall Wace Asset Management Ltd | 0.94 | 328,332 | +89.6 | 06/30/2026 |
| BlackRock Inc | 0.57 | 199,755 | +17.4 | 06/30/2026 |
| Vanguard Fiduciary Trust Co | 0.55 | 192,356 | +0.7 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.70 | 936,927 | +0.0 | 09/30/2026 |
| Fidelity Extended Market Index | 0.47 | 162,535 | -0.5 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Titterton Lewis H jr | Director | 1,054,003 | 3,267,409 $ | Oct 23, 2026 | direct |
| Kumar Amit | Chief Executive Officer | 680,000 | 2,108,000 $ | Oct 22, 2026 | direct |
| Baskies Arnold M | Director | 140,572 | 435,773 $ | Sep 24, 2026 | direct |
| Catelani Michael | President, COO, & CFO | 50,000 | 155,000 $ | Sep 30, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 23, 2026 | Titterton Lewis H jr | Director | Buy | 8,000 | 2.98 | 23,840 |
| Oct 22, 2026 | Kumar Amit | Chief Executive Officer | Buy | 8,000 | 2.72 | 21,760 |
| Sep 30, 2026 | Catelani Michael | President, COO, & CFO | Buy | 5,500 | 2.84 | 15,620 |
| Sep 24, 2026 | Kumar Amit | Chief Executive Officer | Buy | 7,000 | 2.78 | 19,460 |
| Sep 24, 2026 | Baskies Arnold M | Director | Buy | 5,000 | 2.76 | 13,800 |
| Sep 23, 2026 | Titterton Lewis H jr | Director | Buy | 49,036 | 2.69 | 131,907 |
| Sep 10, 2026 | Kumar Amit | Chief Executive Officer | Buy | 3,000 | 2.75 | 8,250 |
| Sep 10, 2026 | Titterton Lewis H jr | Director | Buy | 10,000 | 2.73 | 27,300 |
| Sep 10, 2026 | Kumar Amit | Chief Executive Officer | Buy | 5,000 | 2.76 | 13,800 |
| Jul 31, 2026 | Kumar Amit | Chief Executive Officer | Buy | 5,000 | 3.47 | 17,350 |
| Jul 27, 2026 | Baskies Arnold M | Director | Other | 5,428 | 3.46 | 18,781 |
| Jul 27, 2026 | Baskies Arnold M | Director | Other | 6,000 | 3.13 | 18,780 |
| Jul 27, 2026 | Kumar Amit | Chief Executive Officer | Buy | 5,000 | 3.44 | 17,200 |
| Jul 27, 2026 | Kumar Amit | Chief Executive Officer | Buy | 3,188 | 3.37 | 10,744 |
| Jul 24, 2026 | Kumar Amit | Chief Executive Officer | Buy | 3,000 | 3.73 | 11,190 |
| Jul 20, 2026 | Kumar Amit | Chief Executive Officer | Buy | 5,000 | 3.46 | 17,300 |
| Jul 20, 2026 | Titterton Lewis H jr | Director | Buy | 12,000 | 3.47 | 41,640 |
| Jul 15, 2026 | Titterton Lewis H jr | Director | Buy | 2,797 | 3.28 | 9,174 |
| Jul 10, 2026 | Kumar Amit | Chief Executive Officer | Buy | 5,000 | 3.04 | 15,200 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.